Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Anti-Bacterial Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anti-Asthmatic Agents < Anti-Bacterial Agents < Anti-HIV Agents  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 137.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000123 (2021) Joshuan J. Barboza ; Diego Chambergo-Michilot ; Mariana Velasquez-Sotomayor ; Christian Silva-Rengifo ; Carlos Diaz-Arocutipa ; Jose Caballero-Alvarado ; Franko O. Garcia-Solorzano ; Christoper A. Alarcon-Ruiz ; Leonardo Albitres-Flores ; German Malaga ; Patricia Schlagenhauf ; Alfonso J. Rodriguez-MoralesAssessment and management of asymptomatic COVID-19 infection: A systematic review.
000142 (2021) Massimo Caracciolo ; Pierpaolo Correale ; Carmelo Mangano ; Giuseppe Foti ; Carmela Falcone ; Sebastiano Macheda ; Maria Cuzzola ; Marco Conte ; Antonella Consuelo Falzea ; Eleonora Iuliano ; Antonella Morabito ; Michele Caraglia ; Nicola Polimeni ; Anna Ferrarelli ; Demetrio Labate ; Marco Tescione ; Laura Di Renzo ; Gaetano Chiricolo ; Lorenzo Romano ; Antonino De LorenzoEfficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients.
000195 (2021) Pallavi Dubey ; Bhaskar Thakur ; Sireesha Reddy ; Carla A. Martinez ; Md Nurunnabi ; Sharron L. Manuel ; Sadhana Chheda ; Christina Bracamontes ; Alok K. DwivediCurrent trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis.
000227 (2021) Guillaume Hache ; Jean Marc Rolain ; Philippe Gautret ; Jean-Claude Deharo ; Philippe Brouqui ; Didier Raoult ; Stéphane HonoréCombination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
000271 (2021) Mark Szendrey ; Jun Guo ; Wentao Li ; Tonghua Yang ; Shetuan ZhangCOVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.
000277 (2021) Vong Sok ; Florence Marzan ; David Gingrich ; Francesca Aweeka ; Liusheng HuangDevelopment and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.
000408 (2020) Giovanni Sisti ; Antonio Schiattarella ; Andrea SistiTreatment of COVID-19 in Pregnancy with Hydroxychloroquine and Azithromycin: a case report.
000455 (2021) Thomas F. O'Connell ; Christopher J. Bradley ; Amr E. Abbas ; Brian D. Williamson ; Akash Rusia ; Adam M. Tawney ; Rick Gaines ; Jason Schott ; Alex Dmitrienko ; David E. HainesHydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
000459 (2021) Basma S. Mansour ; Noha A. Salem ; Ghada Abdel Kader ; Gamal Abdel-Alrahman ; Omayma M. MahmoudProtective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model.
000469 (2020) Zeinab Imani-Saber ; Hajar Vaseghi ; Mojdeh Mahdian ; Fatemeh Safari ; Mohsen GhadamiVariable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
000481 (2020) Elias Ortiz Molina ; Rafael Hernandez Pailos ; Maria Pola Guillen ; Ana Pascual Pedreno ; Eduardo Rodriguez Rodriguez ; Antonio Hernandez MartinezCOVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
000492 (2021) Iwein Gyselinck ; Wim Janssens ; Peter Verhamme ; Robin VosRationale for azithromycin in COVID-19: an overview of existing evidence.
000527 (2021) Philippe Gautret ; Jean-Christophe Lagier ; Stéphane Honoré ; Van Thuan Hoang ; Didier RaoultClinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
000528 (2021) Guogen Shan ; Weizhen WangAdvanced statistical methods and designs for clinical trials for COVID-19.
000530 (2021) Philippe Colson ; Bernard La Scola ; Jean-Christophe Lagier ; Philippe Gautret ; Didier RaoultInterpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000531 (2021) Philippe Gautret ; Van Thuan Hoang ; Jean-Christophe Lagier ; Didier RaoultEffect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
000533 (2021) Tuan V. NguyenUncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
000534 (2021) Philippe Gautret ; Stéphane Honoré ; Jean-Christophe Lagier ; Didier RaoultSafety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000535 (2021) Mohamed O. SaadLetter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000536 (2021) Marcelo Rodrigues Dos SantosReferring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.
000537 (2021) Carlos Gustavo WambierFocus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Anti-Bacterial Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Anti-Bacterial Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Anti-Bacterial Agents
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021